$4.73▾ 4.25%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
NeOnc Technologies Holdings, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days3 articles
3 bullish0 neutral0 bearish
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier
NeOnc Charting New Nasal Route to Treating Brain Cancer
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout